Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
MRSA outbreaks impose substantial financial burdens on hospitals and patients, with MRSA bacteremia costing approximately seven times more to treat than MSSA bacteremia.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Clifford et al. (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: